An increase in urinary frequency is observed in winter months, particularly at night, by many men. The low temperatures cause blood vessels of the skin to narrow by nature, forcing more blood to the ...

Amgen Inc. ends 2025 on a high note. Thanks to strong sales of Repatha and Imdelltra, it raised its full-year 2025 revenue guidance from $35-$36 billion to $35.8-$36.6 billion. So, sales of Repatha, a ...

Please provide your email address to receive an email when new articles are posted on . The VESALIUS-CV trial evaluated the impact of the PCSK9 inhibitor evolocumab on risk for major adverse ...

The White House announced it has signed nine new agreements with pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi ...

Bristol Myers Squibb BMY and Amgen AMGN are among the largest global biotechnology companies with broad and diverse portfolios. Bristol Myers Squibb is focused on discovering, developing and ...

Amgen highlighted its robust performance in 2024, achieving 14 products annualizing over $1 billion in sales. CEO Robert ...

High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...

Q. My doctor prescribed rosuvastatin for high cholesterol. After taking it for six to nine months, I noticed that my cognitive function had slipped. I would not be able to find the word I was looking ...

If an ounce of prevention is worth a pound of cure, research in the primary and secondary prevention space in 2025 added up to sizeable gains when it comes to tackling atherosclerotic cardiovascular ...